EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Viral vector-based therapeutic HPV vaccines

Teng Ji, Yuchuan Liu, Yutong Li, Chuanfen Li, Yingyan Han

Clinical and Experimental Medicine · 28.08.2024 · 24 (1)

DOI: 10.1007/s10238-024-01470-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Experimental Medicine, online erschienen am 28.08.2024. Verfasst von Teng Ji und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Hu…. Hauptthemen laut MEDLINE: Papillomavirus Vaccines, Papillomavirus Infections, Genetic Vectors. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Replication-defective viral vector vaccines have several advantages over conventional subunit vaccines, including potent antibody responses, cellular responses critical for eliminating pathogen-infected cells, and the induction of highly immunogenic and durable immune responses without adjuvants. The Human papillomavirus (HPV), a microorganism with over 200 genotypes, plays a crucial role in inducing human tumors, with the majority of HPV-related malignancies expressing HPV proteins. Tumors associated with HPV infection, most of which result from HPV16 infection, include those affecting the cervix, anus, vagina, penis, vulva, and oropharynx. In recent years, the development of therapeutic HPV vaccines utilizing viral vectors for the treatment of premalignant lesions or tumors caused by HPV infection has experienced rapid growth, with numerous research pipelines currently underway. Simultaneously, screening for optimal antigens requires more basic research and more optimized methods. In terms of preclinical research, we present the various models used to assess vaccine efficacy, highlighting their respective advantages and disadvantages. Further, we present current research status of therapeutic vaccines using HPV viral vectors, especially the indications, initial efficacy, combination drugs, etc. In general, this paper summarizes current viral vector therapeutic HPV vaccines in terms of HPV infection, antigen selection, vectors, efficacy evaluation, and progress in clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus VaccinesPapillomavirus InfectionsGenetic VectorsHumansAnimalsFemaleClinical Trials as Topic

Stichwörter der Autor:innen

Viral vectors; Human papillomavirus; Therapeutic vaccine; HPV-related malignanc…

Substanzen

Papillomavirus Vaccines

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Key Laboratory of Cancer Invasion and Metastasis (Ministry of Education), Hubei Key Laboratory of Tumor Invasion and Metastasis, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wu…
  • The Second Clinical Medical College, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. hanyingyan1…

Zitieren

APA

Ji, T., Liu, Y., Li, Y., Li, C., & Han, Y. (2024). Viral vector-based therapeutic HPV vaccines. Clinical and Experimental Medicine, 24(1). https://doi.org/10.1007/s10238-024-01470-5

Vancouver

Ji T, Liu Y, Li Y, Li C, Han Y. Viral vector-based therapeutic HPV vaccines. Clinical and Experimental Medicine. 2024;24(1). doi:10.1007/s10238-024-01470-5

BibTeX
@article{Ji2024,
  author = {Ji, Teng and Liu, Yuchuan and Li, Yutong and Li, Chuanfen and Han, Yingyan},
  title = {Viral vector-based therapeutic HPV vaccines},
  journal = {Clinical and Experimental Medicine},
  year = {2024},
  volume = {24},
  number = {1},
  doi = {10.1007/s10238-024-01470-5}
}
Kostenlos starten →